Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA): fair value, margin of safety and Wheel Score

Is DMAA undervalued?

DMAA closed at 10.88 on 5 Nov 2026 against a GLS average fair value of 10.74 - 1.3% above fair value, which our scans read as "fairly priced". 2 of 5 models are above the current price. There is no discount to lean on here, so the margin of safety is not the reason to look at the stock.

There is a wide gap between EPV (3.37) and GLS Growth (18.57). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files DMAA under Speculative - it is losing money or its Piotroski health score is 3 or lower - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for DMAA

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

Quality and financial health

Drugs Made In America Acquisition Corp. Ordinary Shares scores only 3 of 9 on the Piotroski F-score, which fails the "Piotroski 6 or more" Wheel Trade Filter. A reading this low means several of the basic tests - positive earnings, positive operating cash flow, falling debt, no new share issuance - are not met. A GLS Moat score of 2.6/10 is a weak reading: the accounts do not show returns and margins that competitors have been unable to wear down, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC 2.6%, ROE 2.6%, ROA 2.5% - with debt at 0.00 times equity and negative free cash flow.

Drugs Made In America Acquisition Corp. Ordinary Shares pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.

Institutional ownership scores 7/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Wheel Score 13: No options

No options are listed on Drugs Made In America Acquisition Corp. Ordinary Shares in our nightly snapshot, so it fails the first Wheel Trade Filter (options that actually trade) (it reads 13, under 70) and is left out of every options scan; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 9k shares a day on a market cap of $264M, with a beta of 0.00 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score rates that fair.

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for DMAA in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Shell Companies

The 12 companies below are the closest to Drugs Made In America Acquisition Corp. Ordinary Shares by market cap within the Shell Companies industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

⚖ Compare DMAA with 7 of them   All Financial Services stocks →